Stephen C. Peiper, MD

Contact Dr. Peiper

1020 Locust Street
Jefferson Alumni Hall,
Suite 279
Philadelphia, PA 19107

(215) 955-5060
(215) 955-5058 fax

Most Recent Peer-reviewed Publications

  1. Erratum: Correction: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer (eLife (2018) 7 PII: e69256)
  2. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis
  3. S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
  4. Commercial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular assays: Superior analytical sensitivity of cobas SARS-CoV-2 relative to NxTAG CoV extended panel and ID NOW COVID-19 test
  5. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke
  6. Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation
  7. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients
  8. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes
  9. Multiple tumor suppressors regulate a hif-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
  10. Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature
  11. The Future Is Today
  12. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
  13. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  14. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  15. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
  16. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma
  17. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  18. Immunohistochemistry successfully uncovers intratumoral heterogeneity and widespread co-losses of chromatin regulators in clear cell renal cell carcinoma
  19. Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma
  20. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin
  21. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors
  22. The Pons Asinorum of Diagnostic Genomics
  23. Regulatory circuit of PKM2/NF-κB/MIR-148a/152-modulated tumor angiogenesis and cancer progression
  24. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory
  25. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer